Determination of Chemical Composition and In Vitro Dissolution Profiles of Herbal Drug Products Containing Ginkgo biloba Available on the Brazilian Market
被引:0
|
作者:
Kratz, Jadel M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, BrazilUniv Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
Kratz, Jadel M.
[1
]
Terrazas, Claudia B.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, BrazilUniv Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
Terrazas, Claudia B.
[1
]
Motta, Monica J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, BrazilUniv Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
Motta, Monica J.
[1
]
Reginatto, Flavio H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, BrazilUniv Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
Reginatto, Flavio H.
[1
]
Simoes, Claudia M. O.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, BrazilUniv Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
Simoes, Claudia M. O.
[1
]
机构:
[1] Univ Fed Santa Catarina, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
来源:
LATIN AMERICAN JOURNAL OF PHARMACY
|
2008年
/
27卷
/
05期
关键词:
Brazil;
Chemical composition;
Ginkgo biloba;
Herbal drug products;
D O I:
暂无
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Determination of Chemical Composition and In Vitro Dissolution Profiles of Herbal Drug Products Containing Ginkgo biloba Available on the Brazilian Market. The present study evaluated by HPLC the contents of flavonoid glycosides, terpene lactones and ginkgolic acids of six herbal drug products containing Ginkgo biloba, available on the Brazilian market, as well as their dissolution profiles. The results showed that five of the six evaluated products do not present adequate chemical composition because the contents of their active substances are not in accordance to the limits proposed by Commission E. Therefore, their therapeutical use is not recommended.